摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methoxy-1-propoxy-4-(1-propenyl)benzol | 92666-24-5

中文名称
——
中文别名
——
英文名称
2-Methoxy-1-propoxy-4-(1-propenyl)benzol
英文别名
3-methoxy-4-propyloxy-1-trans-propenyl-benzene;2-methoxy-4-propenyl-1-propoxy-benzene;3-Methoxy-4-propyloxy-1-(propen-(1)-yl-(1t))-benzol;3-Methoxy-4-propyloxy-1-trans-propenyl-benzol;2-Methoxy-4-propenyl-1-propoxy-benzol;3-Methoxy-4-propyloxy-1-propenyl-benzol;2-methoxy-4-[(E)-prop-1-enyl]-1-propoxybenzene
2-Methoxy-1-propoxy-4-(1-propenyl)benzol化学式
CAS
92666-24-5
化学式
C13H18O2
mdl
——
分子量
206.285
InChiKey
BMXUXMQRAIBQHK-GQCTYLIASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    304.6±22.0 °C(Predicted)
  • 密度:
    0.975±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BENZIMIDAZOLE DERIVATIVES AS SELECTIVE BLOCKERS OF PERSISTENT SODIUM CURRENT<br/>[FR] DÉRIVÉS BENZIMIDAZOLE EN TANT QUE BLOQUEURS SÉLECTIFS DU COURANT DE SODIUM PERSISTANT
    申请人:ALLERGAN INC
    公开号:WO2013101926A1
    公开(公告)日:2013-07-04
    The present invention is directed to methods of treating diseases or conditions mediated by elevated persistent sodium channel, such as ocular disorders, pain, multiple sclerosis, and seizure disorders utilizing a compound of Formula (I) or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising said compound, wherein variables R, R1, R2, R3, R4, R5, m, and n in Formula (I) are as defined herein.
    本发明涉及治疗由持续性钠通道升高介导的疾病或症状的方法,例如眼部疾病、疼痛、多发性硬化和癫痫症,利用化合物I的方法或其药学上可接受的盐或包含该化合物的药物组合物,其中化合物I中的变量R、R1、R2、R3、R4、R5、m和n如本文所定义。
  • BENZIMIDAZOLE DERIVATIVES AS SELECTIVE BLOCKERS OF PERSISTENT SODIUM CURRENT
    申请人:Allergan, Inc.
    公开号:US20130172342A1
    公开(公告)日:2013-07-04
    The present invention is directed to methods of treating diseases or conditions mediated by elevated persistent sodium channel, such as ocular disorders, pain, multiple sclerosis, and seizure disorders utilizing a compound of Formula I or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising said compound, wherein variables R, R 1 , R 2 , R 3 , R 4 , R 5 , m, and n in Formula I are as defined herein.
    本发明涉及使用I式化合物或其药学上可接受的盐或包含该化合物的药物组合物来治疗由持续性钠通道升高引起的疾病或症状,例如眼部疾病、疼痛、多发性硬化和癫痫等。其中,I式中的变量R、R1、R2、R3、R4、R5、m和n的定义如本文所述。
  • Dehydrozingerone, Chalcone, and Isoeugenol Analogues as in Vitro Anticancer Agents
    作者:Jin Tatsuzaki、Kenneth F. Bastow、Kyoko Nakagawa-Goto、Seiko Nakamura、Hideji Itokawa、Kuo-Hsiung Lee
    DOI:10.1021/np060252z
    日期:2006.10.1
    Twenty-eight compounds related to dehydrozingerone ( 1), isoeugenol ( 3), and 2-hydroxychalcone ( 4) were synthesized and evaluated in vitro against human tumor cell replication. Except for isoeugenol analogues 27-35, most compounds exhibited moderate or strong cytotoxic activity against KB, KB-VCR ( a multidrug-resistant derivative), and A549 cell lines. In particular, chalcone 15 showed significant cytotoxic activity against the A549 cell line with an IC50 value of 0.6 mu g/mL. Furthermore, dehydrozingerone analogue 11 and chalcones 16 and 17 showed significant and similar cytotoxic activity against both KB (IC50 values of 2.0, 1.0, and 2.0 mu g/mL, respectively) and KB-VCR (IC50 values of 1.9, 1.0, and 2.0 mu g/mL, respectively) cells, suggesting that they are not substrates for the P-glycoprotein drug efflux pump.
  • Oxokohlenstoffe und verwandte Verbindungen. 27. Synthese von Dihydrocyclobuta[a]naphthalen-1,2-dionen und Cyclobuta[a]naphthalen-1,2-dionen durch Anellierung von Alkoxy-(1-alkenyl)benzolen mit 3-Chlor-3-cyclobuten-1,2-dion. Anwendungsbereich und Grenzen
    作者:Arthur H. Schmidt、Gunnar Kircher、Mathias Spring、Markus W. Hendriok、Christian Künz
    DOI:10.1002/prac.199733901100
    日期:——
    The reaction of alkoxy-(1-alkenyl)benzenes with semisquaric chloride (3) has been investigated systematically. 1,2-Dialkoxy- and 1-alkoxy'-2-alkoxy ''-4-(1-alkenyl)benzenes (6a-j) and (11a-i) react with 3 to give the 3,4-dihydrocyclobuta[a]naphthalene-1,2-diones (8a-j) and (12a-i). Treatment of the dihydrocyclobuta[a]naphthalene-1,2-diones with 1.2 equiv. bromine effects dehydrogenation and affords cyclobuta[a] naphthalene-1,2-diones (9a-e) and (13b-f). Any efforts to extend this annulation reaction to dimethoxy-(l-alkenyl)benzenes with the methoxy groups in other than the 1,2-positions, e. g. 14a, b, 16a, b have been unsuccessful. The reaction of 1,2,3-trimethoxy-4-(l-propenyl) [and 4-(1-butenyl)]-benzenes (18a) and (18b) with semisquaric chloride (3) leads to the elimination of HCl and CH3OH and gives 5,6-dimethoxy-3-methyl [and 3-ethyl]-cyclobuta[a]naphthalene-1,2-diones (20a) and (20b). The reaction pathway of this novel annulation reaction is discussed.
  • Mueller; Karczag-Wilhelms, Chemische Berichte, 1954, vol. 87, p. 1727,1732
    作者:Mueller、Karczag-Wilhelms
    DOI:——
    日期:——
查看更多